Drug intelligence / Profile preview

half of kidney nourishing blood

Development stage: Preclinical
Administration: Intravenous, Subcutaneous

Overview

Half of kidney nourishing blood is a Traditional Chinese Medicine (TCM) formulation, specifically a 50% dose of the Bushen Shengxue prescription. In Traditional Chinese Medicine, Bushen Shengxue translates to 'nourishing kidney and generating blood'. This formulation is being investigated for its potential to treat aplastic anemia by addressing imbalances related to kidney function and blood production according to TCM principles.

Other names: 服用补肾生血方50%量Bushen Shengxue prescription 50% dose

Beyond the preview

Go deeper on half of kidney nourishing blood.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on half of kidney nourishing blood.

Explore the full profile